Trevarx Biomedical, Inc. — Form D

Trevarx Biomedical, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-20. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-09-20
• Form: D
• Accession: 0001783904-22-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $500K
• Amount sold: $500K
• Investors: 10
• Date of first sale: 2022-09-15
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-459264

Issuer

• Name: Trevarx Biomedical, Inc.
• CIK: 0001783904
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2016
• Address: 2929 ARCH STREET, 3RD FLOOR, PHILADELPHIA, PA, 19104
• Phone: (206) 949-4956

Officers, directors & promoters (2)

Other filings by this issuer (2)

More

• CIK 1783904 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search